Townsquare Capital LLC Bicycle Therapeutics PLC Transaction History

Townsquare Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$12.95 - $46.99 $91,789 - $333,065	-7,088 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$40.12 - $59.5 $3,771 - $5,593	-94 Reduced 1.31%	7,088 $311,000
Q4 2021 Feb 11, 2022	SELL	$41.7 - $61.14 $25,228 - $36,989	-605 Reduced 7.77%	7,182 $437,000
Q3 2021 Nov 15, 2021	SELL	$27.95 - $44.24 $1,145 - $1,813	-41 Reduced 0.52%	7,787 $324,000
Q2 2021 Aug 16, 2021	BUY	$27.0 - $32.28 $211,356 - $252,687	7,828 New	7,828 $250,000

30.6M

85.5K

11.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $601M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.